Waltham, Massachusetts – (The Hosting News) – January 16, 2009 – Web host and integrated data management solutions firm, Phase Forward Incorporated, will release financial results for the quarter ending December 31, 2008.
The company will hold a conference call with investors, hosted by Bob Weiler, President and Chief Executive Officer, along with Rodger Weismann, Senior Vice President and Chief Financial Officer.
The company plans to discuss its third quarter 2008 financial results and its outlook for the 2009 year. The call will be held on Thursday, February 5, 2009, at 5:00 p.m. (EST). The investor conference call will be available via live webcast on Phase Forward’s web site at www.phaseforward.com under the tab ”Investors.”
To participate by telephone, the domestic dial-in number is 888-680-0878 and the international dial-in is 617-213-4855. The access code is 23115725. Investors are advised to dial into the call at least ten minutes prior to the call to register. Participants may pre-register for the call. Pre-registrants will be issued a pin number to use when dialing into the live call which will provide quick access to the conference by bypassing the operator upon connection. The webcast will be available for replay until Thursday, March 5, 2009 on the ”Investors” page of Phase Forward’s website.
Phase Forward is a provider of web hosting and integrated data management solutions for clinical trials and drug safety. The company offers solutions for electronic data capture (InForm), phase I clinic automation (LabPas), clinical data management (Clintrial), clinical trials signal detection (CTSD), strategic pharmacovigilance (Empirica Signal) and Signal Management, adverse event reporting (Empirica Trace), applied data standards (WebSDM) and web-integrated interactive voice response systems (Clarix). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 280 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter and Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency.
To learn more, please visit: www.phaseforward.com.